Connor, Clark & Lunn Investment Management (CC&L)
ASPX

Connor, Clark & Lunn Investment Management (CC&L)’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,300
Closed -$832K – 715
2015
Q1 		$832K Sell
8,300
-100
-1% -$6.66K 0.01% 331
2014
Q4 		$441K Buy
+8,400
New +$247K ﹤0.01% 408

Connor, Clark & Lunn Investment Management (CC&L)'s ASPX Position: Q2 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 8,300 shares — an estimated $832K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $832K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 8,300 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $832K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $832K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2015, filed 14 Aug 2015.